Liquid biopsy is a minimally or noninvasive technique for finding that circulates tumor components in biofluids. Generally, blood is used but any biological fluid can be used such as urine, pleural effusion, and saliva. Cells, including cancer cells, release DNA fragments called circulating tumor DNA, which represents a fraction of the circulating free DNA (cell-free DNA) and which represents the main biomarker user, through necrosis and apoptosis mechanisms; it is also possible to use exosomes, that is, subcellular structures encapsulated in the membrane containing proteins and nucleic acids released by tumor cells, microRNA, platelets. In this chapter, we aimed to summarize liquid biopsy applications in a real-world setting.

La Mantia M., Cutaia S., Gristina V., Galvano A., Capoluongo E., Rolfo C., et al. (2022). Liquid biopsy: a right tool in a right context?. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 31-45). Elsevier [10.1016/B978-0-12-822703-9.00013-2].

Liquid biopsy: a right tool in a right context?

Cutaia S.;Gristina V.;Galvano A.;Rolfo C.;Incorvaia L.;Bazan V.
2022-01-01

Abstract

Liquid biopsy is a minimally or noninvasive technique for finding that circulates tumor components in biofluids. Generally, blood is used but any biological fluid can be used such as urine, pleural effusion, and saliva. Cells, including cancer cells, release DNA fragments called circulating tumor DNA, which represents a fraction of the circulating free DNA (cell-free DNA) and which represents the main biomarker user, through necrosis and apoptosis mechanisms; it is also possible to use exosomes, that is, subcellular structures encapsulated in the membrane containing proteins and nucleic acids released by tumor cells, microRNA, platelets. In this chapter, we aimed to summarize liquid biopsy applications in a real-world setting.
2022
La Mantia M., Cutaia S., Gristina V., Galvano A., Capoluongo E., Rolfo C., et al. (2022). Liquid biopsy: a right tool in a right context?. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 31-45). Elsevier [10.1016/B978-0-12-822703-9.00013-2].
File in questo prodotto:
File Dimensione Formato  
LB in a right context.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 188.09 kB
Formato Adobe PDF
188.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/625460
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact